In addition to a shortened latency, the proportion of female mice that developed mammary tumors was higher in the K14CreERβF/Fp53F/F group (74%) compared with the K14Crep53F/F cohort (66%), suggesting that loss of ERβ is specifically associated with mammary tumorigenesis. Here, ESR2 is linked to breast cancer.